BEOVU 6 mg/.05mL (Brolucizumab INJECTION, SOLUTION) 6 mg/.05mL

BEOVU 6 mg/.05mL is an intravitreal injection solution containing brolucizumab. This medication is used to treat certain eye conditions, including wet age-related macular degeneration (AMD). Learn more about brolucizumab and its uses.

Strength

6 mg/.05mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BEOVU 6 mg/.05mL is primarily used for the treatment of wet age-related macular degeneration (AMD). This condition affects the macula, the central part of the retina, and can lead to vision loss. Brolucizumab is designed to inhibit vascular endothelial growth factor (VEGF), which plays a role in the abnormal blood vessel growth associated with wet AMD. Patients often wonder, 'What is brolucizumab used for?' and the answer lies in its ability to help manage and slow the progression of this eye disease.

Side Effects

Common effects of BEOVU 6 mg/.05mL may include eye redness, floaters, and increased eye pressure. Some patients may also experience eye pain or discomfort following the injection. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

BEOVU 6 mg/.05mL should be handled with care, as it is intended for intravitreal use only. The medication should be stored and administered under sterile conditions to minimize the risk of infection. Patients should follow their healthcare provider's instructions for post-injection care to ensure the best possible outcomes.

Avoid Interactions

BEOVU 6 mg/.05mL may interact with other medications, particularly those that affect the eyes or immune system. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with brolucizumab, so it's important to discuss any dietary concerns with a healthcare professional.

Frequently Asked Questions

BEOVU 6 mg/.05mL is used to treat wet age-related macular degeneration (AMD), a condition that can lead to vision loss.

BEOVU 6 mg/.05mL is administered as an intravitreal injection by a healthcare professional.

Common side effects may include eye redness, floaters, and increased eye pressure.

Patients should consult their healthcare provider before using BEOVU 6 mg/.05mL with other medications to avoid potential interactions.

BEOVU 6 mg/.05mL should be stored under sterile conditions and handled with care.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.